Sourasky Medical Center (Ichilov)
| イスラエル | トルコ | オーストリア | |
| サイバーナイフ | から $17,500 | から $4,750 | から $50,000 |
| サイバーナイフ治療 | から $17,800 | から $4,750 | から $35,000 |
| サイバーナイフ | から $17,500 | から $25,000 | から $25,000 |
| サイバーナイフ | - | から $6,000 | - |
Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.
He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.
Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).
His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.
He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.
He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
アリ・ラファエル教授――テルアビブ・スラスキー医療センター（イキロフ、テルアビブ）トランスレーショナル腫瘍学部門長および臨床がん研究部門研究員。患者一人ひとりのニーズに寄り添う個別対応のアプローチが高く評価されています。
資格および患者への貢献：
腫瘍科デイホスピタルを統括し、国家ゲノム医療プロジェクトを主導。最先端の研究へのアクセスを提供しています。
主任副研究者および主任研究者として、腫瘍内mRNA投与やウイルス製剤を含むフェーズI〜IIIの多数の臨床試験に携わってきました。患者は革新的な治療法への参加機会を得られます。
米国および英国における国際的な臨床経験を有し、世界水準の治療基準と先進的なプロトコルの適用を保証しています。
国際学術団体の会員（ESMO、IASLC、ISLB、ISCORT、Israeli Medical Association）。最新の治療基準を活用し、国際的な研究に参画しています。
ICH GCP R2、Israeli MOH Guidelinesをはじめ、インフォームドコンセント、副作用管理および患者安全に関する最新課程を含む国際臨床実践基準に基づき、定期的に専門知識の更新および研修を実施しています。
ラファエル教授は、精密な治療レジメンの選択、革新的手法の導入、そして細やかな患者対応により高い信頼を得ており、治療のすべての段階において患者が安心して療養に臨める環境を提供しています。
Bookimed社は、イスラエルには高度な医療機器と優秀な医師が揃っているため、サイバーナイフ治療に適した場所だと考えている。
世界中から多くの患者が治療を求めてイスラエルを訪れ、医療ツーリズムの利用者も多数います。最も多い出身国はアメリカ、ロシア、カナダです。イスラエルの医師はサイバーナイフを用いた治療経験が豊富で、がん、神経疾患、その他の重篤な疾患において高い成功率を誇っています。医療スタッフは非常にプロフェッショナルで、患者のあらゆる質問や不安に丁寧に対応し、安心感を与えてくれます。デニス・モシャー氏をはじめとする医療コーディネーターは、地元のレストランや観光スポットのおすすめなど、患者への手厚いサポートを提供しています。
結論として、イスラエルは最新の医療機器、高度な資格を持つ医師、そして世界中から集まる多数の医療ツーリストを擁し、サイバーナイフ治療を受けるのに最適な国です。患者からの肯定的なレビューと、クリニックが提供する治療の高い成功率は、医療を求める患者にとってイスラエルが優れた選択肢であることを示しています。
Bookimedのランキングによると、サイバーナイフ治療を提供するイスラエルの病院トップ5が明らかになった。
Bookimedは、サイバーナイフ手術を成功させたイスラエルの優秀な医師を特定しました。
Top CyberKnife specialists in Israel for brain tumors include internationally trained neurosurgeons and radiation oncologists. Experts at institutions like Hadassah and Sourasky hold board certifications from Israel and the US. These doctors use robotic systems to treat inoperable tumors without invasive surgery.
Bookimed Expert Insight: Data shows a concentration of top-tier expertise at Hadassah Medical Center in Jerusalem. Dr. Andry Key and Dr. Samuel Moskovichi offer rare specialization in skull base and pituitary surgeries. Patients benefit from doctors who combine international fellowships with high research output in neuro-oncology.
Patient Consensus: Patients are often surprised by the precision of the treatment and the lack of hair loss or swelling. Many note that Israeli protocols use fewer sessions than in other countries, which helps speed up recovery. They also suggest hiring a local coordinator to help with scheduling at busy centers like Sheba or Hadassah.
Highly recommended Israeli doctors for CyberKnife treatment of prostate cancer include board-certified oncologists and radiotherapists. Top specialists like Dr. Raanan Berger and Dr. Orit Gutfeld lead major cancer centers. They offer precision radiotherapy using advanced protocols at JCI-accredited facilities in Tel Aviv and Jerusalem.
Bookimed Expert Insight: Israeli oncology centers are unique because several top-tier specialists, like Dr. Ari Raphael and Dr. Raanan Berger, serve as principal investigators for clinical trials. This lets patients access treatment protocols that integrate genomic tumor profiling. Consultations with these leaders typically range from $650 to $750 at major centers like Sheba or Sourasky.
Patient Consensus: Patients value how quickly they can start treatment in Israel compared to other countries. They often notice a significant drop in PSA levels within six months of the procedure. Many are surprised that the non-invasive sessions allow them to return to work in days.
Top Israeli radiation oncology departments are led by board-certified experts at JCI-accredited centers. Dr. Orit Gutfeld directs the Radiotherapy Institute at Sourasky Medical Center. Dr. Auala Hubert leads gastrointestinal tumor treatment at Hadassah Medical Center. These specialists use CyberKnife for precision tumor targeting.
Bookimed Expert Insight: Leadership at these centers often involves highly specialized sub-focuses. For instance, Dr. Auala Hubert at Hadassah Medical Center holds a rare combination of 30+ years in radiotherapy and gastroenterology. This overlap allows for exceptionally precise CyberKnife planning for complex abdominal tumors, which requires deep anatomical knowledge.
Patient Consensus: Patients note that department heads often provide detailed physics explanations about how the radiation tracks tumors. They feel relieved by the collaborative approach where chiefs from different centers share protocols to improve results. Many are surprised by how quickly they recover after targeted CyberKnife sessions.
Israel offers specialized oncologists who combine CyberKnife expertise with a primary focus on gastrointestinal cancers. These experts work within dedicated cancer centers at major institutions like Hadassah and Sheba. They utilize advanced robotic radiosurgery for complex tumors in the liver, pancreas, and colon.
Bookimed Expert Insight: Data shows that while several clinics offer CyberKnife, specialized GI focus is concentrated. Dr. Auala Hubert at Hadassah Medical Center stands out for 30+ years of experience. Her dual background in oncology and radiotherapy is rare. Dr. Ari Raphael offers consultations from $750 for precision genomic profiling. Choosing a doctor with specific GI leadership roles often leads to more personalized radiation plans.
Patient Consensus: Patients note that sessions feel precise and efficient compared to traditional radiation. Some mention being surprised that doctors might suggest proton therapy for better motion management. Travelers often appreciate having translators and airport pickup coordinated for their multi-day treatment schedules.
Leading Israeli CyberKnife physicians are board-certified radiation oncologists and neurosurgeons with extensive training from institutions like Oxford and Harvard. These specialists often hold dual certifications in oncology and radiotherapy. They also lead national genomic medicine initiatives to provide precise tumor targeting.
Bookimed Expert Insight: Data shows that top Israeli specialists often combine CyberKnife expertise with genomic profiling. Dr. Ari Raphael at Sourasky Medical Center offers consultations for $750 and leads national genomic initiatives. This allows physicians to match radiation intensity to the specific genetic makeup of a tumor.
Patient Consensus: Patients note that a doctor's specific experience with stereotactic radiosurgery is more important than their general surgical background. Many were surprised by how much the physician's personal role in treatment planning influenced their results. They recommend asking if the specialist has performed thousands of CyberKnife procedures specifically.